Cargando…

Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis

BACKGROUND: There are no data on neutralising antibodies to interferon-beta and its clinical implications in Chinese patients with multiple sclerosis (MS). OBJECTIVES: The objectives of this study were to investigate the prevalence of neutralising antibodies among Chinese patients with relapsing MS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Alexander Y, Ip, WK, Au, Cheryl, Lau, KK, Wong, Winnie, Yip, KK, Yeung, Jonas, Li, SH, Li, Patrick, Lee, Ryan, Siu, Deyond, Abrigo, Jill, Wong, Adrian, Mok, Vincent, Chan, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637981/ https://www.ncbi.nlm.nih.gov/pubmed/29051830 http://dx.doi.org/10.1177/2055217317733485

Ejemplares similares

Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis
por: Zhao, Lin, et al.
Publicado: (2020)

Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands
por: Zhao, Lin, et al.
Publicado: (2020)

Moyamoya disease in a patient with neuromyelitis optica
por: Chan, Nathan H., et al.
Publicado: (2014)

Differential heterologous neutralisation profile against strains within DENV-3 genotype II
por: Tan, K.K., et al.
Publicado: (2021)

Cognitive domain deficits in patients with aneurysmal subarachnoid haemorrhage at 1 year
por: Wong, George Kwok Chu, et al.
Publicado: (2013)

High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis
por: Lau, Alexander, et al.
Publicado: (2018)

The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome
por: Chong, Wai Po, et al.
Publicado: (2006)

The Spatial Associations of Cerebral Blood Flow and Spontaneous Brain Activities with White Matter Hyperintensities—An Exploratory Study Using Multimodal Magnetic Resonance Imaging
por: Shi, Lin, et al.
Publicado: (2017)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015)

The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis
por: Madsen, Claus
Publicado: (2017)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

The Additional Contribution of White Matter Hyperintensity Location to Post-stroke Cognitive Impairment: Insights From a Multiple-Lesion Symptom Mapping Study
por: Zhao, Lei, et al.
Publicado: (2018)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Paolicelli, Damiano, et al.
Publicado: (2009)

Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
por: Jankovic, Slobodan M
Publicado: (2010)

Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is There an Odd One Out?
por: Clapin, Alexis
Publicado: (2012)

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
por: Lemos, Livia Lovato Pires de, et al.
Publicado: (2017)

Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.
por: Bell, J. B., et al.
Publicado: (1994)

Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study
por: Lau, George KK, et al.
Publicado: (2010)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

Osteolipoma in the Forearm
por: Kwan Ip, Natalie Siu, et al.
Publicado: (2018)

Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a
por: Kolind, Shannon, et al.
Publicado: (2022)

Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial
por: Kamm, Christian Philipp, et al.
Publicado: (2012)

Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway
por: Yeung, Kit San, et al.
Publicado: (2017)

Piperacillin-Tazobactam Allergies: An Exception to Usual Penicillin Allergy
por: Wong, Jane CY, et al.
Publicado: (2020)

Advances in immunomodulating therapy of HBV infection
por: Hui, Chee-Kin, et al.
Publicado: (2005)

Effects of Structured Versus Usual Care on Renal Endpoint in Type 2 Diabetes: The SURE Study: A randomized multicenter translational study
por: Chan, Juliana C., et al.
Publicado: (2009)

Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China
por: Xu, Yan, et al.
Publicado: (2019)

Capripoxvirus antibodies detection: Relationship between the two methods alpha and beta of virus neutralisation test
por: Hamidouche, Mohamed, et al.
Publicado: (2018)

Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong
por: Fan, Florence Sin Ying, et al.
Publicado: (2021)

Prognosis of elite basketball players after an Achilles tendon rupture
por: Siu, Ronald, et al.
Publicado: (2020)

Peak width of skeletonized mean diffusivity and its association with age-related cognitive alterations and vascular risk factors
por: Lam, Bonnie Yin Ka, et al.
Publicado: (2019)

IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS
por: Scagnolari, Carolina, et al.
Publicado: (2014)

Neutralisation pockets and spectral lines
por: Gröbner, Oswald
Publicado: (1972)

On Toxic Neutralisations: II. Reconstitution
por: Richardson, Benjamin Ward
Publicado: (1894)

Mechanisms of Rhinovirus Neutralisation by Antibodies
por: Touabi, Lila, et al.
Publicado: (2021)

MRI-based Alzheimer’s disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer’s disease
por: Liu, Wanting, et al.
Publicado: (2021)

Neutralising antibody titers and COVID outcomes in cancer patients
por: Lee, Matilda Xinwei, et al.
Publicado: (2023)

Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care
por: Chien, Wai Tong, et al.
Publicado: (2013)

Self correction of anterior crossbite: a case report
por: Mok, Chung Wai, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h9nbh6ludg6r2o6uijstikhhbm